XML 89 R90.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Details 2) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2014
Significant unobservable inputs
Dec. 31, 2013
Significant unobservable inputs
Mar. 31, 2014
Preferred Stock
Significant unobservable inputs
PWERM
Minimum
Dec. 31, 2013
Preferred Stock
Significant unobservable inputs
PWERM
Minimum
Mar. 31, 2014
Preferred Stock
Significant unobservable inputs
PWERM
Maximum
Dec. 31, 2013
Preferred Stock
Significant unobservable inputs
PWERM
Maximum
Mar. 31, 2014
Preferred Stock
Significant unobservable inputs
PWERM
Average
Dec. 31, 2013
Preferred Stock
Significant unobservable inputs
PWERM
Average
Mar. 31, 2014
Preferred Stock
Significant unobservable inputs
Market Comparable Companies
Minimum
Dec. 31, 2013
Preferred Stock
Significant unobservable inputs
Market Comparable Companies
Minimum
Mar. 31, 2014
Preferred Stock
Significant unobservable inputs
Market Comparable Companies
Maximum
Dec. 31, 2013
Preferred Stock
Significant unobservable inputs
Market Comparable Companies
Maximum
Quantitative information about the Company's Level 3 fair value measurements                              
Time until future exit event           2 months 12 days 0 years 3 months 18 days 4 months 24 days            
Probability of Abaloparatide coming to market           65.00% 65.00% 75.00% 75.00%            
Discount rate (as a percent)           20.00% 20.00% 40.00% 40.00%            
Long-term revenue growth rate under scenario one (as a percent)           2.00% 2.00% 117.00% 117.00% 27.00% 27.00%        
Long-term pretax operating margin under scenario one (as a percent)           13.00% 13.00% 79.00% 79.00% 68.00% 68.00%        
Discount for lack of marketability (as a percent)           6.00% 10.00% 33.00% 36.00%            
Revenue multiple                       3.6 3.2 8.4 8.0
Revenue years used in calculation of average estimated long-term revenue growth rate under scenario one                   16 years 16 years        
Years used in calculation of average estimated long-term pretax operating margin under scenario one                   17 years 17 years        
Stock asset       $ 1,200,000                      
Warrant liability 4,550,000 1,945,000 830,000 4,600,000 1,900,000                    
Stock liability         $ 5,300,000